I would like to extend my appreciation for the remarkable work. The methodology applied appears promising, and we are eager to explore its application in addressing various other diseases.
In our attempts to replicate the approach for different diseases, we encountered challenges in identifying FDA-approved drugs. Despite utilizing the method outlined in the article to locate FDA-approved medications for TNBC, our findings were not as extensive as those cataloged in "ApprovedDrugs_TNBC.txt."
To further our understanding and facilitate the successful application of this method to diverse diseases, could you kindly provide a detailed explanation of how the drugs mentioned in the article were identified? Such insights would greatly aid us in adapting this methodology for other diseases.
I would like to extend my appreciation for the remarkable work. The methodology applied appears promising, and we are eager to explore its application in addressing various other diseases.
In our attempts to replicate the approach for different diseases, we encountered challenges in identifying FDA-approved drugs. Despite utilizing the method outlined in the article to locate FDA-approved medications for TNBC, our findings were not as extensive as those cataloged in "ApprovedDrugs_TNBC.txt."
To further our understanding and facilitate the successful application of this method to diverse diseases, could you kindly provide a detailed explanation of how the drugs mentioned in the article were identified? Such insights would greatly aid us in adapting this methodology for other diseases.